Global Phototherapy Equipment Market Trends Analysis Report 2023-2030: LED-Based Phototherapy Devices Gain Traction, Propelling Market Growth in Skin Disease Treatment
24 oct. 2023 10h03 HE
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Phototherapy Equipment Market Size, Share & Trends Analysis Report By Product (Conventional Phototherapy Equipment), By Application (Skin Diseases...
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
23 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract...
New Data Shows ZORYVE® (Roflumilast) Cream 0.3% Provided Measurable Improvement of Plaque Psoriasis in Nearly All Individuals in DERMIS Trials
20 oct. 2023 08h00 HE
|
Arcutis Biotherapeutics, Inc.
New individual patient response data showed nearly all individuals (95%) treated with ZORYVE® (roflumilast) cream 0.3% had a measurable improvement in PASI
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
16 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent...
Mindera Health™ Announces Contract With General Services Administration®
10 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announced that the General Services Administration (GSA) has granted a 5 year contract award to Mindera Health enabling access...
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children Ages 6 to 11
06 oct. 2023 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced the FDA has approved an sNDA to expand the indication of ZORYVE (roflumilast) cream 0.3%.
Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
03 oct. 2023 10h00 HE
|
Mindera Health
San Diego, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider...
Biologics and Personalized Medicine to Fuel Growth in the Plaque Psoriasis Treatment Market, With Telemedicine and Digital Health Playing a Role
22 sept. 2023 08h43 HE
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Plaque Psoriasis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Global Dermatology CRO Market 2023-2030: Intellectual Property Challenges Pose Hurdles to Dermatology CRO Industry Growth
22 sept. 2023 06h58 HE
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical...
Interchangeable Biosimilars Market revenue to hit USD 65 Billion by 2035, says Research Nester
11 sept. 2023 07h00 HE
|
Research Nester
New York, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The global Interchangeable Biosimilars market size is slated to expand at ~ 20 % CAGR between 2023 and 2035. The market is poised to garner a revenue of...